Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hard to tell.. seemed ho-hum.. just moving along with an endpoint a couple months from now as to #3 trials. They like the lack of side effects so far versus the main competitor and will price about the same... if I made it all out anyway. Terrible accents..
Can anyone short story the terrible accent in the conference call?
The Prospectus uses .78? as a long term holder basis, bringing SP average to >< 1.28.... I don't see any short term benefit and when the company discusses REE openly states sale of the division goes to A holders.
Sorry, This is trading stock short term only, not long term investment vehicle. I might add the company made the statement about Presidential policy not being a effect-or... 'Comon Man!' will decimate this sector.
Think it will find support >< 1.25?
okay... look at that price drop! Gee... where is the Shelf offering now?
Maybe someone might give me a clue.. why was a Shelf announced during the day? Why would anyone buy at Shelf pricing now that SP is collapsed?- just to use as proof of available counts so to enable shorting? Was it shorted by the same people, that were going to buy 'the shelf', thereby they already have profits.. in shorting the Shelf?
Seems pretty sloppy in methods and questionable as to management competence.
If anyone knows of Shelf situation I would like to hear... get no response from management.. as if it were a pinkie!
The only basis I can imagine for the company to create a shelf but destroy it SP value is there would be news to re-instate a SP back to the Shelf pricing and the outfit running a 'Green shoe' effort to get Shelf offered SP at least a wash sp... unless the 'big short' was the 'shelf sp profit structuring.
Seems the OTC is starting to respond to the new symbol. Well... maybe .. soon..
Thanks! Poland has just started reopening the last 2 weeks from Covid lockdown, I think that has most everything to do with this delay..
I don't think the Stock issue isn't halted, a requirement for active trades, but ley me know if I'm wrong. Imo, the 'halt' was in part due to last LOI where disreputable CSE broker dealers shorted Stil a million shares all at once, then covered based on a self proclaimed eval on stocks of the 2 companies.. and the Broker Dealers in the Inverse Funds obviously didn't buy up the stock to previous levels.. they are only 'there' to take value out, not put value into a CSE stock.
So the halt is essentially needed at least till a further LOI examination and eval followed by a vote of stockholders. In this Covid Emergency there is far less advancements for every Cannabis stock issue as to investing in startups, but we should see that change this summer.. and Stil does need to keep people informed as to the LOI and halt.
A Canadian and British listed stock exchanged stock counts with different fiat rates have to be adjusted, lots of filing is needed. Additionally both companies with a LOI can ask for additional info, filings made... it isn't like the LOI happens by itself either, Investors have to vote after further investigations, legal work being firmed up. A number of 6 companies are being joined up, why the impatience?
I think conservation of cash best for the Corona timelines. There is massive commerce reductions everywhere and in this sector.
Coming out the other side I'm pretty sure there will be any number of small CBD companies that went into this economic downturn far worse off than Stil had in reserves. Lots were right on the edge in finances and certainly there will not be much in the way of start up capital for new entrants.... perhaps well into next year.
It is what it is, but I expect a serious down turn in biomass production this year in the industry and a washing out of overproduction stores of CBD distillates in the Industry as well.
We are both older guys, we don't yet know how we will see the Chinese attempt to take over Banking that is about to hit and there is going to be some real frictions in their supply lines of CBD items as well as the rest of the world.
I hope we both get through this with families intact and look to investments as secondary at the moment.
Stock count doesn't mean anything to be OTCBB.
Shorts went from >< 10,000 to >< 100,000 as I see it is indication of average daily shorting having increased 10 fold in a one month period. Just to say, hard to develop value when average trading involves 2/3rd trading daily volume to be short and cover, sell and buys, So yeah, had the Issue gone to OTCBB and eliminated CSE and German platforms I think the Issue would have had a healthier outcome so far.
Keep a close Eye and remember 2008 or at least other people are remembering 2008. Question is therefore, will everyone go to cash?
Short term or until bailouts?
Yeah with the current status I'll get a few more this and next week. With two licensed plants capable of >< 150 million dollars worth of grams at full retail pricing per month one would think this President could get something going. I wouldn't be surprised if a buyout happens for that matter... like CWBHF or CRON or even a Pharm- GWPH or Canopy Growth Corp.
Right now at .10, cash and equipment are worth more that the valuation!
The LOI is off the table but we have Origin now coming on line...
Looked at the new President? Really knows IPOs, Mergers and acquisitions. Stil was fortunate to have him consulting, now very lucky as Pres. Worked on the IPOs of German sportswear manufacturer Adidas and chemicals firm Merck. Van Issum worked on the Eu10.1bn privatization of Deutsche Telekom in 1996 and Eu720m IPO of Portugal Telecom. Has done placements for Heidelberger Druck, Linde and Amadeus, European ECM Dream Team Global Capital 2004, out of the markets 2007 well off, bike riding around the world saying he would never go back to the city life(Rat race?), started a fun Excursion ultimate adventure company till 2010. Turns out he is a big fan of CBDs!
Came on as a consultant for Stillcanna, now President,'never say never' back into 'City life'!!
Things have a way of working themselves out...
Somebody run the numbers on this..
50+ years ago my Father introduced me to Stock vesting when I was 12. The 1st thing he did was make me understand financials. Laborious process for a 12 year old. When I asked why, he said don't invest in something you don't understand.
With the LOI in MOTA there are things I don't understand. I asked for clarification from Jason as to the PEI/Origin, where profits go to in everything, MOTA Jvs.. 'Tolling'.. MOTA paid for cash company... We only have one 'MOTA' company with a said unaudited sales, will Stils last years sales be credit to WHOEVER files fanancials...MOTA? MOTA is so young the Nov 29, 2019 Interim means about nothing.
What are these people actually working on.. where is their cash flows? Any reporting?
Mota Ventures Corp. is pleased to announce that its wholly owned subsidiary Ihuana S.A.S ("Ihuana") has entered into a research cooperation agreement (the "Agreement") with La Fundacion Universitaria de Ciencias de la Salud (The University Foundation of Health Sciences) (the "University") located in Bogota, Colombia. Pursuant to the Agreement, the parties intend to engage in research and formulation of medicinal products made with non-psychoactive cannabis and cannabis byproducts.
Sativida and First Class CBD brands and reporting WHERE?( First Class CBD (then, a division of Unified Funding, LLC) realized approximately C$28.7 million in revenue with an EBITDA of approximately 12.5%)
The LOI has MOTA raising ?5 mill @ .45 PP to get close to Stl's cash holding? At 1.8 ratio? For some infrastructure?
I mean REALLY! And I asked for clarification, I was a little blunt, Jason was a little blunt.... Jason said he was going to present something before LOI was exposed but an unexpected happened and required Jason to halt and report LOI. He said he would give us something.
Bottom line for me, I cannot put more in as a 'Investment' till I know more. Maybe I'll trade some with additional funds, but don't INVEST on unknown/not understood structures.
If someone with more experience can help us out as to how this whole Tolling thing works and more info I'll change my mind.
For now I've still got every share I ever bought.
Heck, I don't even know how the salaries get paid, from MOTA or ongoing in each sub?
Fwiw, large traders traded this down based on 1.8' Of MOTA SP, then MOTA moved down, Stil moved down... and total transactions look matched ><, over two days- pretty stupid panic move it looks to me(Clusterfuck). Same people sold, then bought back lower??!! What if the LOI doesn't go through?
If you are brave go for it, the LOI caught me flatfooted.
I didn't leave. I haven't any windows open to count all 3 exchanges but the one TD platform I do have open showed 1 mill shares transacted(><) with pretty steady buying from noon on. I suspect panic selling with LOI showing share exchange 1.8 ratio in the merger LOI.
Fwiw, there was a unexpected situation that caused the halt 2 days ago, to get the insert of news about the LOI yesterday and restart, to comply with regs concerning disclosure of relevant/material changes.
The Halt, the news, the 'relevant'... were a response to 'unexpected situation' so there was no preparing stock holders in any form of presentation- imo- leading to over reaction...almost even now few traders have looked at the issues, assets or companies involved. Any, in what one could call a kind of reverse merge, having less than majority company position is seen as bad situation, and 'seeing' doesn't seem to have even counted any thing but the '1.8.'.
Blogosphere results were pushing MOTA sp as guidance, MOTO holders didn't like a 45%??... loss in dilutive LOI so they sold off some in a even more thinly traded issue than Stil… which had bashers calling for ever lower prices, back and forth, back and forth with calls for Stil to be valued by Mota sp.
Then today another voluntary halt, might be regulatory agency requests for additional info on LOI as it wasn't exactly planned to be presented as it was, it maybe just more info to be presented by Stil and MOTA as to the LOI... BELATIDLY!!
It may be a rescind of LOI entirely considering the nature of the response by share holders to, lolol.
Which would be sort of ironic wouldn't it, a withdrawn LOI based on market reaction due to poor presentation!
Good thing Stillcanna has their 2 plants, Origin and Nexus already equipped... might slow Horizon- yet to be built but there suppliers outside of China for each component.
Fwiw, this virus(Sars) has a relatively low death rate where all the exclamations about 'Pandemic' statements are being made and already one or more companies are going into trials for solutions.. this number will grow to 6-7 over the next week or so.
While Media doesn't give very good coverage, and are using data showing FDA requirements are that 'solutions' and 'trials' can take years for clickbait, the truth is if the need is there the solution will roll out to match the need, timewise.
If there are little to no ill effects in the trials over the next 2-4 weeks, rollouts will happen.
It is just a bad flu type,antiviral medications are currently being tested to see if they can address symptoms.
Imo, some of the best opportunities in the markets since 2009 will unfold in this mess. Electronics for one... for sure. Both in recovery in China and development outside of China.
Frankly, this paradigm of China being the mass producer for the entire world was going to be reduced at some point for a number of reasons, political or in this case a medical concern.
For our subsector China's disruption in their Hemp/CBD chains will actually be a good thing this and next year. Where all the 'exclamations' are a thing of the past in 3-4 months due to rollouts of solutions.
Halted pending news.
Doing some digging I found that Dragonfly Biosciences, Stillcanna's partner in the Romanian 'Origin' CBD plant is about to rollout a "Cosmetic" line of products. This will definitely be an expansion in CBDs needed and a very fortuitious developement for Stillcanna. Utilizing CBDs inside of 'Cosmetics' can be refered to as 'Nutricosmetics'.
White Paper excerpt:
Cannabidiol (CBD)
The ingredient really expected to boom in 2019 is CBD. Nutraceutical companies as well as food and beverage companies are looking to include this ingredient in their products. It’s expected to make a big impact on the functional food industry, and supplement companies have already started incorporating it into their formulas. The numbers are encouraging, and it might seem like CBD is a goldmine, however, there are a lot of risks along with the benefits for companies to consider.
(White Paper)
Top Nutraceutical Trends of 2019
While hemp might be a valid ingredient for some foods and dietary supplements, CBD, at least in the U.S., most definitely is not.2 In 2018, the FDA approved a drug containing CBD to treat seizures, and other drugs containing CBD are undergoing clinical trials. Since the FDA has approved the ingredient for use in a drug product, it falls outside of the definition of a dietary supplement. And since these products and the many conditions that they’re supposed to be able to treat are at the top of the FDA’s priority list, including CBD in a dietary supplement is a major risk. The agency has stated that it takes multiple factors into consideration before deciding whether or not to initiate an enforcement action against companies marketing these products. However, the plethora of warning letters issued to companies selling supplements containing CBD should serve as a cautionary tale.
(California may well change this paradigm as early as end of March 2020 with changes in regs placed via Bill #64)
Trend #2: Nutricosmetics Another trend that is picking up momentum in 2019 is the concept of “beauty from within.” This is the idea that what we ingest can have a direct bearing on our physical appearance. Since this involves nutraceuticals branching into the cosmetics market, these supplements have been aptly named nutricosmetics. Perhaps the best-known example of this is collagen, which has long been a supplement meant to improve the appearance of skin, hair, and nails.
If some of these nutricosmetics have been around for years, why should they be a trend for 2019? For one thing, the market is already valued at $121 billion globally and should reach $179 billion by 2022,1 which represents a nearly 50 percent increase. Another reason is that there’s a huge opportunity in the generation that’s moving into this market. Anti-aging products are traditionally marketed to those who are already showing signs of aging, or those who will be soon. The success of nutricosmetics depends on an entirely different age group and involves preventing those wrinkles or age spots from appearing in the first place.
With Nutraceuticals AND Nutricosmetics commerce there is a 1/4 Trillion dollars of commerce... Stillcanna is rolling out formulas to apply to EACH commerce Stream.
"Beverages" will get attention next.
Now we will enter the time of revenues. Unknown to most investors is that DragonFly has been taking Private Placements, about 50 million so far, that will be spent on their product buildout. Products made from Origin(Some no doubt from Nexus) and Stillcanna. DragonFly, a private company, has access to >< 5000 'doors' in the E.U., will go public I figure later this year or early 2021. Lost in the background noise is that Origin was always designed to be a provider of "net profits" base customer/Dragonfly enabling Stillcanna a burn rate modifier towards all 3 planned plants buildouts. I expect somewhere between 12 and 24 million a year revs from Origin to Stil for the first YOY production. Other people told me to be patient as to earnings- wait till end of 1st quarter for revs/2020 March and they seem to have been correct. All things taken into account I am awaiting Horizon plant buildout confirmation. Tripling capacity of the two present plants come 2021. With this in mind, 2021, I am looking to see a modulation in SP and actually wish it to not go above .50 for another 60-90 days, so to eliminate 10 million plus in warrants being taken. Just me being greedy. Stil may need the sale of the warrants and nets from same, maybe over the next 1/4- through June.. we just don't know yet... which will be priced well above .50.. but we will see.. so with a tripling of production comes the need for more 'dragonflys'/customer base. some changes are coming to the U.S. markets, first will be California... and we know what that will imply:)
Finally!!! Ministry of Health in Romania gives approval for Origin plant... #2 CBD Stillcanna plant will come on line! https://www.accesswire.com/576790/Stillcannas-Romanian-Based-ORIGIN-CBD-Extraction-Facility-Receives-Green-Light-from-Ministry-of-Health-and-Anti-Drug-AgencyThis timing is very advantageous as Stillcanna's partner for the England markets where limitations in growth rates of CBDs was being affected by the U.K. Food Safety government department to where there had been no, zero, nada, nothing guidelines about dosages. Causing great confusion about safety for consumers.That changed last week, maximum daily dosages(done via COT panel evaluations on toxicity) was established, along with labeling requirements! This is huge for the U.K. markets and for the world which has yet to address the matter in this manner.1.6 million CBD users in the U.K. will grow quite a lot, knowing safety guidelines now... and Dragonfly and Stillcanna are poised to service that industry market with virtually any combinations of CBDs Dragonfly wishes for.
One can go on the major sites that sell bulk orders of the various applications, where as many as 100 variations exist for CBD products.. Nutraceuticals being one area that has 100 billion$+ just in the U.S. market. Bulk sales of Isolated CBDs converted to Nano particles, then encapsulated and placed into Emulsions is the general method. To say, all together, all over the world a potential trillion dollar of commerce may happen where CBDs can be entered into the products.
MEANWHILE!! the U.K. FSA(Food Safety) authority finally came out with its first guidelines(Derived from the COT Panel evaluations)- 70 mgs maximum recommended daily. Not a huge number but >< 2xs what was generally 'recommended' by most sellers previously or matching the sellers already defined 'maximum'. Standards for labeling, pregnancy,lactating age medical claims contents ect ect also follow what the Industry wants in 'self regulation'. 'The Association for the Cannabinoid Industry (ACI) has welcomed todays regulatory and precautionary advice'(Dragonfly is a major participator in the ACI) this will lead to faster growth in consumption in the U.K. now. Looking forward to the California bill(64 or whatever # assigned to the Proposal)) to get on the Governors desk(by end of March?) where I would not be surprised to see something of the same situation as in the U.K. currently ;)
Lots of consolidation in the well overblown MJ stocks for sure. Way too high of prices for way too low of net nets in most companies that paid way too much for ancillary buyouts and taking on debt and dilutions... all in my own opinion of course.
On the CBD side I believe regulatory headwinds have had more to do with the sector than actual buildouts of companies specific to CBDs.
But both subsets of products are still gaining growth in use, CBDs eventually will get more growth imo.
Stil just got its sales going, don't know the ongoing costs for production for certain and how effective the B2B Broker Dealer networks will respond, but we should know pretty well in this quarter how going forward things will generally shake out.
I'm pretty sure at this point everyone is well aware the Canadian Stock Markets sell down any stock that isn't producing product and making sales...
We should see a reversal imo with a growing sales amounts. Have you been following legislations in the U.S.? Seems 'Novel Foods' applications are flooding into the E.U. Commission as well.
I don't know how much DD the average person does... but I found a YouTube channel with the cultivation video raw. The company that was bought by Stillcanna for cultivating Hemp has a number of vids and only the most recent is after being purchased. That vid shows the sizes of different fields, different approaches to loading cuts, different stages of growth in the different fields and a pic of the side of a Hemp bale where I estimate about 600pds+ per bale judging on the compression of the bale.
It helps me understand that the harvest was well above initial planning last spring.
I'm estimating, with last releases on effectiveness, >< 25,000 kilos of Isolation kilos from last years cultivation.
I'm approaching 100K shares also:)
https://www.youtube.com/channel/UCVwOCZ-gRtSp2Axd6LAHK4w
For what it is worth, I played 'phone tag'/twitter with Jason this morning and he is in Toronto making a presentation, other management is progressing through Ministry of Health in Romania for a time frame on licensing(for Origin), the Nexus plant in Poland is still on 60 hour 12/7 shifts with the non Kilo production hours(other 12 hours a day) having the plant upgraded/get GMP and other qualifications and plant is operating smoothly. I have queried about the B2B/Broker dealer response and other Items but it is not information he will put out unless in general release.
bar180, when the company has 2 shifts... or 24/7 operation at Nexus the product valuation will be such as to provide ><15 Cents per share nets income imo. Not {13} cents per share nets income... and the market will take notice. Sorry if I wasn't more clear. Does that meet with your approval now?
From the News of Dec. 12 About 40 kilos per day production on 12/7 basis and the company going to 24/7 basis in this Q1 of 2020 with 80 kilos per day production and measuring a market for bulk CBDs at only $2,000 per kilo(not seen this low yet) we see a 50 million dollar YOY product creation with a constant dropping of unit production cost. I'm going out on a limb here.. to say we may well see a ongoing(before dedicating net net profits back into the company) a 'Net profit of about 15 cents per share on just the Nexus plant for YOY.
As to what that might be comparable in the CBD space,,,, Charlottesweb had about the same Nets' in 2018. With Origin coming on line soon, a equaling of 2019 Charlottesweb Nets I expect. With the buildout of the next plant, Horizon scheduled for this spring and summer, Stil should be producing roughly the same quantity, quality and slightly lower cost per Kilo than Charlottesweb and Mile High- leaders in the CBD space, for 2021.
How everything shakes out with these 'Big 3" and each competing with each other remains to be seen... but it is becoming very apparent many small producers are going to have to leave the creation space... leaving creation more and more this year to the large bulk producers... they simply will not have economy of size even producing at 100 kilo per year levels.
There is no telling of how the 'Market' will respond to any stock, but 15 cents net per share and a bright future is a fine starting point to gain attention.
For those even marginally curious why Stil put the new Rotochrome(estimated cost at 850,000$ per unit) in the Origin plant, why so much has been spent on consulting, why the Romanian are unaware of this relatively new technology..
http://rotachrom.com/videos/
" RotaChrom’s patented downstream platform is capable of direct Scale up in a few weeks: from grams/batch to tons/month production all on the same machine"
"iCPC
The largest centrifugal partition chromatographic instrument in the world. RotaChrom is the sole manufacturer and distributor of the industrial scale CPC instrument and provides various products and services facilitating downstream silica gel free preparative industrial scale production. Buying an iCPC device provides many technical and economic advantages to your current and future downstream method development."
http://rotachrom.com/products/
State of the art, 5 cents per gram, operationally capable of being tuned to separation not only of pesticides and THC for CBD... but also CBG and CBN molecules... which will be the next 'big thing' in Cannabinol products.
CBD stocks bumped up Wednesday with Federal Bill 5587 getting listed.
https://www.cannalawblog.com/will-the-fda-soon-treat-hemp-cbd-as-a-dietary-supplement/
Also there are some rumors around that by February 28th Governor Newsome may find another CBD bill on his desk- The California House and Senate overwhelmingly approved AB 228 last year but the Governor essentially let it die. One can get a Marijuana product with about the same content of CBDs 'per serving/joint' legally in California... but not a Hemp 'Serving' of CBDs that isn't serving up THC as in the 'pot joint'. More than a little hypocritical... one can sell a marijuana THC/CBD infused cookie but not a Hemp no THC/CBD cookie... in a same scenario. Obviously a political point in referencing Pot sales imo. May seem like a fine distinction as to food additives, but Newsome hasn't been all that.. ahhh… shall we say.. NOT SUSEPTABLE to corruption, lol.
"15+ >< in sales YOY" = 15 million+ >< in sales YOY basis
Yeah.. I try to stay accurate as to news releases and running the obvious market prices/production quantities... on other sites get called a 'pumper'. One of the rather gross people that insulted everyone here and was kicked off is on other sites, getting timed out' for same behavior.. in which I engendered said 'pumper status, lol!
I don't know if I mentioned, Dragonfly, Stil's distillate partner in Romania(Origin plant) that Stil is servicing out of the Polish plant (Nexus) till Origin gets last EPA approval... is taking Private Placement for readying listing itself. About 50 million so far in placements >< @ .87? per. So Dragonfly expects CBD markets to expand.
I watched a FSA(Food service Agency- U.K.) about the 21st of this month and they are still differing to E.U. decisions/apply to the E.U. for approvals in food additives. Dragonfly, Mile High, Charlottesweb.. all the big players have been going through two different manners via two different activist approaches. One E.U. approval but in a short manner of approval(>< 4 months versus the standard 1.4 years like as if in a drug application) and also trying method '2', trying to convince U.K. regulators concentrated CBDs are NOT... 'novel'. I highly suspect a number of those said 'big players' have made submissions (4 month example(has to do with a reg#4) and I suspect the involved activist groups are attempting to get a scheme where a company can >< duplicate another's product constituent ingredients already approved but adding to a different 'food'. So to say there should little difference between a candy bar or bowl of oatmeal if same CBDs are in each.
Long story short, these 'big players' each are moving up their expectations for a given... if unsaid.. reason.
I'm still waiting on a news release also, Jason told me they would be working on one about a week ago. I garnished from other investors whom have shared that NEXUS was working a second shift last month to bring NEXUS to all those qualifications mentioned in the Dec. 12th news- good thing.
So Dragonfly has plenty of bucks to buy product with(the founders are very well off from previous businesses), the industry expects expansion, Origin needs one last approval, Jason told me the one shift operation at NEXUS is running smoothly...
I think as long as one or other of the Stil plants is producing 15+ >< in sales YOY from about this point/quarter the company should be good to go as to working on the Horizon plant buildout.
I remember when I was working Jason's schedule of 100 hours a week.. did it for about 6 years running, just about ruined my health:)))) He's getting things done but has another year of those 100 hour weeks ahead of him!
I've followed the CSE short sell counts for a while on this one. The "Count" is taken 2 days out of every 30 days/two week intervals, the count is for that day- the shorts existing that day. Going back many months it was as high as 400K, it dropped more or less steadily to 1st 1/2 December with 25K, and picked back up the second half December.. these numbers are approximates as I'm too lazy to open the files again, but they are close. In the "Canadian" markets it is relevant the trading is essentially thin, that market is designed to have.
What is looked at often as a model in the U.S. as mostly (Shorting) for Customer use for expectations and covering risk.. of course Broker Dealers use shorting to balance their risk/books and make market.
In Canada, shorting by broker dealers in "Inverse Funds" is a real and present manner of making money at the trader desks inside the Inverse Funds. Some might say the same exists in America, like in ETFs as it were... but due to 'Canada' being a 'thin market' the ability to short is needed and allowed and necessary for that market to even exist. To say.. without buying pressure, every Canadian stock would be worthless, shorted into the ground... that might define how the Canadian markets work.
You are correct that about 2/3rds of the stocks ongoing volume has been 1/3rd shorting, 1/3rd covering shorts, 1/3rd retail buying(few long position Institutional Fund buying).
Stillcanna will get some attention if sales happen, if profits are made... and imo, the Canadian market approaches that require a "rush' to overcome Inverse Funds will happen. What the volume will be, when it will happen, if the profits are measured I don't know..... but I added some in December...
Around the net, Germany, Canadian and American stock sites it is deluged with anti-Stillcanna sentiment from a few/same people and the volume of that discourse follows the volume of 'shorts' lolol.
The Moderator of this board has done a good job keeping nitwit knuckle heads from these Inverse Funds away as they are terribly insulting and accusatory... trust me.. other stock trading sites are not near as self policing as here.
Let see if the Founder being in Romania has some relevance, lets see if we get a update soon on sales. I'm keeping in mind this was always going to be a two year plan/buildout of 3 production plants and early in CBD markets expansion.
Now someone can scream at me for 'pumping',,,, what a crazy world startup company vesting is!!!
I emailed back and forth several times to company officials, CEO and Founder, got replies from the Office in Canada when I sent questions as being passed onward when I went that way. Fwiw, any company will ignore certain questions, sometimes it is for protection of the company, lolol, sometimes to protect the stock sales price.
I literally have been told when they could not comment on certain items as 'that would be 'insider' info'(violations). My last e-mail answered two days ago by the Founder was a short one... not very interesting but he indicated he was in Romania...
Left me hoping the Origin plant licensing was being dealt with, my interpretation entirely.
This News was from the Nexus(Poland) plant... delving into latest news and filings about the Romanian plant I see it has been getting 'some love' additional funding towards licensing(Still recently updated news to include reaffirming 'soon'... I also studied up on the "Additional Rotochrom" that was purchased for Origin... I think it is the Model iCPC - 600 kilos per month capacity- reaffirms production capacity expected for Origin. Interestingly, the 'Roto' is used for removing THC and pesticides at a cost of only 5 cents a gram! Amazing the technology jump(If you are into that kind of Technology stuff:) )
I've been in the 'blogosphere' lol. Other sites.
Still has been following for the last two months a update pattern for company development on the 12th of the month... about 10 days from now I expect another one,,,,
Last one highlights...
"Since beginning production over the past few weeks, the Company is pleased to announce it has begun shipping CBD Isolate to Bioscience Enterprises Inc. as outlined in the supply agreement dated May 28, 2019...
The Company is pleased to announce that it has received and has begun fulfilling an order from HempLabs Poland..(one needs to know the mother corporation to Hemplabs to fully understand the signifigance)
The Company is pleased to announce it has begun shipping hemp biomass to Sequoya Cannabis in Poland.
The Company has received over C$1,140,000 in confirmed purchase orders...
All done in 1st month of plant being finished and sales starting.
The facility has the capacity to process 1080 kilos of blended hemp flower at a consistent 6% CBD biomass input into 40 Kilos of CBD Isolate every 12 hours..
Proof of concept and sales"
IMO,,,The present capacity(12/7) will not fill the yearly order expectation, close, but not completely, of already agreed to supplying for the above 'Partners' to the agreements. Still has defined Biosciences wholesale agreement (the base 'Anchor' agreement') as at a price of 2 dollars a gram. So I use that 'base' as determining the base value of '40 kilos a day' valuation= 24 million in product and 'will not fill yearly order expectation'... this means the Poland plant(NEXUS) will need to go to 24/7.... from present 12/7 hours production.(Keeping in mind the wholesale average of pricing for the product internationally is considerably higher)
The company is still awaiting the Romanian(Origin plant) licensing approval which would enable the current 'yearly order expectation' without Nexus going 24/7.... With Nexus operations comes training that may be needed for Origin personnel.. (just as a side note.)
Origin will pickup said '24 million to ?>< 36 million @ 12/7 operations labor hours I believe.
We will see if Nexus operations are leaning towards forward statements soon which requires '24 million YOY a 12/7 hours schedule to be enabled/confimed in the next News release and as per Company statements, two following monthly totals due to delays between originating contact to buyers and final deposits and releases of payments from buyers.....
Just to say...'rubber meets the road time' is now. Fwiw, I added 30k shares in expectation it will happen..
The Cannabis Trades Association which has around 1000 members in 28 countries worldwide, has been battling the EU decision for the last 12 months. I'm looking forward now to the next months FSA meeting in the U.K.!
Currently, the CTA is regulating each one of its members. As part of this process, the CTA has brought in a panel of independent experts called TrustCanna.
TrustCanna is a product certification process which will allow consumers to see which products have been verified and safe to use for the end-user. Effectively, TrustCanna would be the holding body for documentation as to members product analysis. This model can be adopted by other E.U. States which will speed up product entry and avoid the novel food authorization need(European Food Safety Authority (EFSA) ) created earlier, where the EFSA is poorly funded, undermanned so resulting in serious delays and high costs for product approvals.